Programme of Acromegaly Screening in Patients With Associated Somatic Disorders (ACROSCREEN)

Ipsen

Status: Completed

Conditions: Acromegaly

Treatments: Other: Non-interventional cross-sectional survey

Study type: Observational

Funder types: Industry

Identifiers

NCT02020967

A-38-52030-280

Details and patient eligibility

About

The primary objective of the protocol is to define percentage of patients with acromegaly in relation to the total number of screened patients with confirmed clinically significant set of associated somatic disorders with the help of laboratory (Insulin-like Growth Factor I, Growth Hormone, Oral Glucose-Tolerance Test [IGF-1, GH, OGTT]) and instrumental examination methods (Magnetic Resonance Imaging [MRI]).

Enrollment: 367 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Men and women aged 18 years and above with associated somatic disorders observed at the Moscow Endocrinology dispensary or Endocrinology Hospital at First Moscow State Medical University
• Patients who signed the Informed Consent Form for participation in the survey before collection of any information.

Exclusion criteria

• Patient already diagnosed with acromegaly
• Patient's refusal to participate in the survey.

Trial design

367 participants in 1 patient group

Acromegaly patients

Treatment:

Other: Non-interventional cross-sectional survey